Other Transaction IDV HR00112090077
- Not listed
- The federal contract IDV award is a $6,166,364 Other Transaction Agreement issued by the Defense Advanced Research Projects Agency (DARPA) to Episys Science Inc., a minority-owned, woman-owned small business specializing in advanced artificial intelligence and autonomous systems technologies. The contract aims to support DARPA's research project on tactical AI, autonomous systems, complex tracking, and other cutting-edge defense and security capabilities. Episys Science has a history of...
- This federal contract IDV award is a $4,900,000.00 Indefinite Delivery Contract issued by the Air Force to Episys Science Inc., a minority-owned, woman-owned small business prime contractor based in Poway, California. The contract is for advanced research and development related to network collaboration and autonomous capabilities, aligning with the Air Force Research Laboratory's focus on cutting-edge national defense and security technologies. Under this IDV, Episys Science has been awarded...
- This Other Transaction IDV was awarded by the Defense Advanced Research Projects Agency on January 29, 2021 to Synoptic Engineering LLC. The potential value of this IDV is $2,999,862. It was awarded without a set-aside under the Small Business Innovative Research Program Phase II solicitation. Under this IDV, Synoptic Engineering LLC will deliver research and development services to further the Defense Advanced Research Projects Agency's goals. As a Phase II SBIR award, this IDV aims to continue...
- The Other Transaction IDV was awarded by the Defense Advanced Research Projects Agency (DARPA) to Sri International, a non-profit research institute. The contract has a potential value of $999,713.00 and does not utilize any set-asides. The purpose of the IDV, titled "THE MEGAPHONE FINDER", is to provide DARPA with a range of research, development, and advisory services across areas such as biomedical sciences, computing, national defense, and environmental technology. Through this IDV...
- The Defense Advanced Research Projects Agency awarded an Other Transaction IDV to Deepsig Inc. on April 14, 2020. With a potential value of $1,655,083, this IDV aims to support research in accordance with the agency's prototype program. As no set-aside was used, this award is unrestricted. The description indicates the IDV scope involves prototype research, consistent with DARPA's mission to foster innovation for national security. Deepsig will likely provide research, development, testing,...
- The federal contract IDV award is an Other Transaction (OT) Indefinite Delivery Vehicle (IDV) contract awarded by the Defense Advanced Research Projects Agency (DARPA), a defense agency, to Physical Sciences Inc. (PSI), a for-profit research and development company. The $4,796,511.00 ceiling value contract is not set-aside and was awarded on June 26, 2025. The IDV contract supports DARPA's "Large-Area Photocathodes (LAP)" research initiative, as well as other cutting-edge defense and...
- This Other Transaction IDV was awarded by the Defense Advanced Research Projects Agency (DARPA) to Ne47 Bio Inc. on July 15, 2025. The IDV has a total ceiling value of $399,956.00 and is not set aside for any specific business type. The IDV was awarded under DARPA's Biological Technologies Office Office-Wide BAA HR001124S0034. This suggests the contracted products and services are related to biological technologies and research. No additional details on specific tasks orders or price lists...
- The federal contract IDV award is a $499,868 Other Transaction IDV awarded by the Defense Advanced Research Projects Agency (DARPA) to SRI International, a non-profit research and development institute. The contract, titled "EQUIP-A-PHARMA - PHASE 1", does not have a small business set-aside. SRI International, an established provider of scientific, engineering, and technical services to federal agencies, will deliver research and development in support of DARPA's mission. The contract...
- The federal contract IDV award is an Other Transaction (OT) with the Defense Advanced Research Projects Agency (DARPA), a research and development agency within the U.S. Department of Defense. The prime contractor is Leidos, Inc., through its Leidos Solutions Operating Segment division (doing business as SAIC). The OT has a ceiling value of $47,405,247.00 and is for DARPA research projects, with no set-aside used. As an OT vehicle, it provides Leidos flexibility to conduct a wide range of...
- This Other Transaction IDV contract was awarded by the Defense Advanced Research Projects Agency (DARPA), a defense-focused federal agency, to Sri International, a non-profit research and development institute. The IDV has a ceiling value of $999,998 and was awarded on December 15, 2023 with no set-aside. The IDV is titled "SCAVENGE: SURFACE COMPOSITION FOR ADVANCED VELOCITY ENHANCEMENT THROUGH NOVEL GEOMETRIC ENGINEERING" and aims to procure research and development services from...
Episys Science, Inc. was awarded a $999,987 Other Transaction IDV by the Defense Advanced Research Projects Agency on May 1, 2020. The IDV has a potential value of approximately $1 million and does not include any set-asides. Episys Science, Inc. will serve as the prime contractor. Under the IDV, Episys Science, Inc. will provide research and development services to the Defense Advanced Research Projects Agency. As the prime contractor, Episys Science, Inc. will complete work under subsequent task orders or through items listed on pricelists. While full details of work to be performed are not provided, based on the awarding agency it can be inferred the IDV aims to fund innovative research projects related to national security technologies. The IDV structure provides flexibility for the agency to fund various research concepts over the period of performance based on program needs and technological developments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 11/10/21 | |
| P00002 | Funding Only Action | $375.8k | 3/12/21 | |
| P00001 | Exercise an Option | $124.1k | 2/1/21 | |
| Not listed | Not listed | $500.0k | 4/20/20 |